Yuflyma Interactions
There are 540 drugs known to interact with Yuflyma (adalimumab), along with 8 disease interactions. Of the total drug interactions, 292 are major, 240 are moderate, and 8 are minor.
- View all 540 medications that may interact with Yuflyma
- View Yuflyma disease interactions (8)
Most frequently checked interactions
View interaction reports for Yuflyma (adalimumab) and the medicines listed below.
- acetaminophen
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- amitriptyline
- amoxicillin
- atenolol
- atorvastatin
- Aventyl Hydrochloride (nortriptyline)
- Benadryl (diphenhydramine)
- bupropion
- Butalbital Compound (aspirin / butalbital / caffeine)
- calcium carbonate
- cannabidiol
- Celebrex (celecoxib)
- celecoxib
- citalopram
- clonazepam
- Cymbalta (duloxetine)
- Diflucan (fluconazole)
- diphenhydramine
- duloxetine
- enalapril
- ezetimibe
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flovent HFA (fluticasone)
- furosemide
- glipizide
- Humulin 70 / 30 (insulin isophane / insulin regular)
- leflunomide
- prednisone
Yuflyma disease interactions
There are 8 disease interactions with Yuflyma (adalimumab) which include:
- infections
- malignancies
- neurologic reactions
- tuberculosis
- CHF
- COPD
- hematologic abnormalities
- hepatitis B
Report options
QR code containing a link to this page
More about Yuflyma (adalimumab)
- Yuflyma consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
